bluebird bio Inc EHA Data Review - Call Transcript
Ladies and gentlemen, thank you for standing by. Over to the bluebird EHA ASCO webcast. (Operator Instructions)
I would now like to hand the conference to your speaker today, Ingrid Goldberg. Please go ahead, ma'am.
Thank you and good morning, everyone. And thank you for joining this morning's call to discuss clinical data presented at the recent ASCO and EHA meetings. The format for today's call will be brief opening remarks from Nick, and then Joanne will introduce the ide-cel data from ASCO, which will be presented by Anna Truppel-Hartmann, our VP of Late-Stage Oncology Clinical Development. Dave will then walk through the clinical data on beta-thalassemia and sickle cell disease from EHA. And for the Q&A portion, Chip and Philip will also be on the call.
Before we begin, I would like to remind everyone that we make forward-looking statements about future plans and prospects on this call. Actual results may differ materially as a result of various important factors, including those
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
